晚期更年期和减弱的大动脉硬性
Sanna Darvish1, Kevin O Murray1, Sophia A Mahoney1
1Department of Integrative Physiology, University of Colorado Boulder, University of Colorado School of Medicine, Aurora. (S.D., K.O.M., S.A.M., N.S.V., M.C.Z., C.A., M.A.F., D.R.S., M.J.R.).
Hypertension (Dallas, Tex. : 1979)
|January 12, 2026
概括
晚期更年期 (≥55岁) 与心血管疾病风险降低有关. 这项研究在更年期后晚期出现的绝经后妇女中发现了减弱的大动脉硬化,这表明这种保护作用的机制.
科学领域:
- 心血管生理学心血管生理学
- 生殖内分泌学 生殖内分泌学
- 血管生物学 血管生物学
背景情况:
- 更年期晚年 (≥55岁) 与更年期后妇女 (PMW) 心血管疾病 (CVD) 风险降低有关.
- 大动脉硬化是心血管疾病风险的关键因素,但与晚期更年期的关系尚不清楚.
研究的目的:
- 为了研究晚期绝经对绝经后妇女大动脉硬度的影响.
- 为了确定结构和负载依赖因素对大动脉硬性的贡献,与更年期开始的年龄相关.
主要方法:
- 在晚期发病 (≥55岁) 和正常发病 (45-54岁) PMW中测量了带关节脉冲波速率 (PWV_CF).
- 使用指数模型计算了结构和负载依赖的PWV_CF组件.
- 在暴露于PMW血清的小鼠中评估了大动脉环弹性模量,脂管学确定了硬度驱动因素.
主要成果:
- 与正常发作的PMW相比,晚发的PMW中的PWV_CF显著较低 (128cm/s).
- 这种减少的大部分 (约85%) 是由于结构依赖性较低的刚性,而不是血压负荷.
- 暴露于晚发PMW血清的大动脉下方弹性模量与线粒体反应性氧物种依赖性硬度的减少有关,甘油三 (16:0) 被确定为关键驱动因素.
结论:
- 减弱的大动脉硬化,主要是通过减少结构依赖因素,可能解释了晚期更年期妇女观察到的较低心血管疾病风险.
- 这些发现突出了可能的机制,将生殖衰老与血管健康和心血管风险联系起来.
相关概念视频
01:28Menopause
3.5K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:30Coronary Artery Disease I: Introduction
868
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868
01:19The Effect of Aging on Tissues
3.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.2K
01:26Aging
578
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
578
01:26Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311